Results 201 to 210 of about 47,434 (363)

DETECTION OF ctDNA WITH WATER SOLUBLE TETRAPHENYLENE-BASED FLUORESCENCE PROBE

, 2011
Jiake Jin, Xiujuan Chen, Yi Liu, Anjun Qin, Jing Zhi Sun, Ben Zhong Tang   +5 more
openalex   +1 more source

ctDNA Detection Based on DNA Clutch Probes and Strand Exchange Mechanism [PDF]

, 2018
Huan Chang, Yiyi Zhang, Fan Yang, Changtao Wang, Haifeng Dong   +4 more
openalex   +1 more source

Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma: What Are the Current Options?

European Journal of Haematology, EarlyView.
ABSTRACT Mantle Cell Lymphoma (MCL) is an aggressive B‐cell non‐Hodgkin lymphoma characterized by the hallmark t(11;14)(q13;q32) translocation, resulting in cyclin D1 overexpression. Predominantly affecting elderly males, MCL exhibits marked clinical and biological heterogeneity, ranging from indolent SOX11‐negative variants to highly proliferative ...
Santino Caserta, Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Fortunato Morabito, Massimo Gentile   +10 more
wiley   +1 more source

Levels of circulating tumor DNA correlate with tumor volume in gastro‐intestinal stromal tumors: an exploratory long‐term follow‐up study

Molecular Oncology
Patients with gastro‐intestinal stromal tumors (GISTs) undergoing tyrosine kinase inhibitor therapy are monitored with regular computed tomography (CT) scans, exposing patients to cumulative radiation. This exploratory study aimed to evaluate circulating
Roos F. Bleckman, Charlotte M. S. C. Haag, Naomi Rifaela, Gerrieke Beukema, Ron H. J. Mathijssen, Neeltje Steeghs, Hans Gelderblom, Ingrid M. E. Desar, Arjen Cleven, Arja terElst, Ed Schuuring, Anna K. L. Reyners   +11 more
doaj   +1 more source

ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy

, 2016
Fei Ma, Wenjie Zhu, Yanfang Guan, Ling Yang, Xuefeng Xia, Shanshan Chen, Qiao Li, Xiuwen Guan, Zongbi Yi, Haili Qian, Xin Yi, Binghe Xu   +11 more
openalex   +2 more sources

Failure is not final: ctDNA-guided rechallenge therapy in colorectal cancer [PDF]

, 2018
Giulia Siravegna, Alberto Bardelli
openalex   +1 more source

Current Status and Future Perspectives of Molecular Residual Disease Testing in Genitourinary Cancers

International Journal of Urology, EarlyView.
ABSTRACT While the clinical outcome for patients with resectable solid tumors has improved in recent years, the risk of postoperative recurrence underscores the need for effective monitoring in cancer patients. Molecular residual disease (MRD) refers to the presence of microscopic cancer that remains undetectable on conventional imaging or pathology ...
Taigo Kato, Shugo Yajima, Yoshiaki Nakamura, Shin Kobayashi, Hideaki Miyake   +4 more
wiley   +1 more source

ctDNA SNORD3F Hypermethylation is a Prognostic Indicator in EGFR-TKI-Treated Advanced Non-Small Cell Lung Cancer

Cancer Management and Research
Bin Liu,* Bingtian Zhao,* Yan Yin, Yan Jiang, Xue Feng, Lei Wang, Liang Zhai, Guangxin Liu, Dongsheng Shi, Jianwen Qin Department of Respiratory and Critical Medicine, Tianjin Chest Hospital, Tianjin, People’s Republic of China*These authors ...
Liu B, Zhao B, Yin Y, Jiang Y, Feng X, Wang L, Zhai L, Liu G, Shi D, Qin J   +9 more
doaj  

Revisiting Epidermal Growth Factor Receptor (EGFR) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Malignancies. [PDF]

, 2019
PurposeTo date, evidence for tissue epidermal growth factor receptor (EGFR) overexpression as a biomarker for anti-EGFR therapies has been weak. We investigated the genomic landscape of EGFR amplification in blood-derived cell-free tumor DNA (cfDNA ...
Fanta, Paul T, Goodman, Aaron, Kato, Shumei, Kurzrock, Razelle, Lanman, Richard B, Lee, Suzanna, Lippman, Scott M, Mareboina, Manvita, Okamura, Ryosuke, Patel, Sandip P, Raymond, Victoria M, Schwab, Richard B, Sicklick, Jason K, Vu, Peter   +13 more
core   +1 more source

P2.01-128 Low Positivity Rate in T790M Detection with ctDNA in NSCLC and Post EGFR-TKI Progression – Timing or Sensitivity? [PDF]

, 2018
Carlos Gil Ferreira, Mariano Zalis, Mauro Zukin, Clarissa Mathias, Cecília Maria Kalil Haddad, Eldsamira Mascarenhas, Luiz H. Araujo, Tatiane Montella, Marcelo Graziano Custódio, Bruna Florentino Diniz Silva, Carlos D. Bustamante, G. Montenegro, Angelita Muras, Marcelo Reis   +13 more
openalex   +1 more source